P53ABN

Clinical trials for P53ABN explained in plain language.

Never miss a new study

Get alerted when new P53ABN trials appear

Sign up with your email to follow new studies for P53ABN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for aggressive uterine cancer: One-Year pill may keep disease at bay

Disease control Recruiting now

This study tests whether taking a daily targeted therapy pill (olaparib) for one year after standard chemoradiation can prevent endometrial cancer from coming back in patients with a specific genetic change (p53 abnormal). About 554 participants will be randomly assigned to recei…

Matched conditions: P53ABN

Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

P53ABN

Get alerted when new P53ABN trials appear

New hope for aggressive uterine cancer: One-Year pill may keep disease at bay